Search

everythinglearnresearchcommunity

for

Search:↓

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

High-dose corticosteroids can significantly regrow hair in severe alopecia areata.

Current corticosteroid pulse therapy is not very effective for severe rapidly progressive alopecia areata.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

Methylprednisolone infusions can help some people with severe alopecia regrow hair.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

Corticosteroid therapy for alopecia areata can cause severe hip bone damage.

Weekly azathioprine pulse is a better alternative to corticosteroids for treating alopecia areata due to fewer side effects.

New understanding and treatments for hair loss are improving, but more research is needed.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Non-ablative and ablative fractional lasers helped hair growth in some cases without major side effects, but didn't work for all hair disorders.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Dermoscopy effectively distinguishes between acute total hair loss and other types of female hair loss.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Graft rejection in a hand transplant may trigger hair loss due to autoimmune responses.

The excimer lamp is a safe and effective treatment for severe alopecia areata.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Alopecia areata in children is usually mild and effectively treated with strong topical steroids.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

Oral methylprednisolone pulse therapy helped an 11-year-old regrow 80% of his hair in six months.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.